MelanoDB: A dataset of clinical and molecular features of patients with advanced melanoma treated with MAPK inhibitors

Abstract MAPK inhibitors (MAPKi) have revolutionized the treatment of patients with advanced melanoma. However, primary and acquired resistance mechanisms limit their efficacy. Predicting MAPKi response from the tumor baseline features remains challenging due to the limited size of patient cohorts....

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Dandou, Julie A. Vendrell, Jérôme Solassol, Baptiste Louveau, Céleste Lebbé, Samia Mourah, Florian Rambow, Eric Richard, Stanislas Du Manoir, Alain Mangé, Peter J. Coopman, Ovidiu Radulescu, Romain M. Larive
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Data
Online Access:https://doi.org/10.1038/s41597-025-05291-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items